Patient Positioning Applications
-
DNA Analyzer for CYP2C19 Test
Rapid genotyping for antiplatelet therapy. 1 in 3 people carry mutations. 30 percent of Caucasians and 40 percent of Asians carry CYP2C19 mutations that impair drug metabolism. For heart attack patients, most complications from poor Plavix® response occur in the first 24 to 48 hours after cardiac stenting. ...
By Genomadix based in Ottawa, ONTARIO (CANADA).
-
NantHealth healthcare solutions for hospitals and health systems sector
Human cognition can examine a maximum of 5 variables per treatment decision without systems support, and there can be thousands of treatment decision considerations for each patient with ...
By NantHealth, Inc. based in Morrisville, NORTH CAROLINA (USA).
-
Hands-Free Robotic Device for Physiotherapy
REX is used by physiotherapists for people with mobility impairments, in rehabilitation centres in the US, the UK, the Middle East, Australia and New Zealand. ...
By Rex Bionics Ltd based in Auckland, NEW ZEALAND.
-
Targeted genetic sequencing solutions for neurology sector
Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.* Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause ...
By Tesis Biosciences based in Scottsdale, ARIZONA (USA).
-
Secca Therapy - Bowel Incontinence
An estimated 20 million people in the U.S. struggle with bowel incontinence, and an estimated 80% suffer in silence. Secca therapy is a safe, effective, minimally invasive procedure to treat bowel incontinence. Secca therapy is an innovative treatment option for patients with BCD, who have not responded to conservative treatments and would like to avoid invasive surgery or implants. ...
By Restech based in Houston, TEXAS (USA).
-
Breast MRI System for Clinical Indications
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
By Aurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA).
-
Covid-19
SFA Therapeutics novel immunomodualtor, SFA006 is planned for testing in COVID-19 Patients 4th Quarter 2020. The trial will test the compound’s ability to prevent the onset of Cytokine Storm Syndrome (CSS) and progression to Acute Respiratory Distress Syndrome (ARDS) in COVID-19 positive patients. Patients will be dosed and monitored for symptom progression hospitalization and ...
By SFA Therapeutics, Inc. based in Jenkintown, PENNSYLVANIA (USA).
-
Surgical Facemasks for Healthcare Industry
The Communicator™ provides clear communication between the patient and healthcare provider. The Communicator™ improves compliance where mask protection is needed. Fewer medical errors allow for positive patient outcomes and increased patient satisfaction. Understanding is key to making sure patients understand follow up care and medication instructions. ...
By Safe’N’Clear, Inc. based in Davidson, NORTH CAROLINA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you